$15.35
-0.62-3.88%
Últ. Act.: Oct 2, 7:33 PM
$15.14
-0.83-5.2%
Sutro Biopharma (STRO) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-2.22 | $-3.04 | $-4.52 | $-3.70 |
| Actual | $-2.33 | $-2.94 | $-5.29 | $-6.70 |
| Surprise | -4.95% | +3.29% | -17.0% | -81.1% |
| Revenue | ||||
| Estimate | $11.1M | $7.7M | $8.6M | $8.8M |
| Actual | $9.8M | $14.5M | $11.6M | $9.7M |
| Surprise | -11.2% | +88.1% | +34.9% | +10.1% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-2.03 | $-2.25 | $-1.85 | $-1.65 |
| Revenue | ||||
| Consensus | $12.2M | $12.7M | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 12, 2026 | $-2.33 | $-2.22 | -4.95 % |
| Q1 | May 14, 2026 | $-2.94 | $-3.04 | 3.29 % |
| Q4 | Mar 23, 2026 | $-5.29 | $-4.52 | -17.0 % |
| Q3 | Nov 6, 2025 | $-6.70 | $-3.70 | -81.1 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 12, 2026 | $9.84M | $11.08M | -11.2 % |
| Q1 | May 14, 2026 | $14.52M | $7.72M | 88.1 % |
| Q4 | Mar 23, 2026 | $11.65M | $8.64M | 34.9 % |
| Q3 | Nov 6, 2025 | $9.69M | $8.81M | 10.1 % |